An Image Dataset of Common Skin Diseases of Bangladesh and Benchmarking Performance with Machine Learning Models

Skin cancer can be life-threatening if not diagnosed early, a prevalent yet preventable disease. Globally, skin cancer is perceived among the finest prevailing cancers and millions of people are diagnosed each year. For the allotment of benign and malignant skin spots, an area of critical importance in dermatological diagnostics, the application of two prominent deep learning models, VGG16 and DenseNet201 are investigated by this paper. We evaluate these CNN architectures for their efficacy in differentiating benign from malignant skin lesions leveraging enhancements in deep learning enforced to skin cancer spotting. Our objective is to assess model accuracy and computational efficiency, offering insights into how these models could assist in early detection, diagnosis, and streamlined workflows in dermatology. We used two deep learning methods DenseNet201 and VGG16 model on a binary class dataset containing 3297 images. The best result with an accuracy of 93.79% achieved by DenseNet201. All images were resized to 224x224 by rescaling. Although both models provide excellent accuracy, there is still some room for improvement. In future using new datasets, we tend to improve our work by achieving great accuracy.

Accurate dermatological diagnosis naturally necessitates equitable performance across diverse populations, yet a systematic lack of expertly annotated images, especially for underrepresented skin tones and rare diseases, impedes progress toward measurably fair methods. We introduce cgDDI (Controllable Generation of Diverse Dermatological Imagery), a hybrid framework that (1) synthesizes realistic healthy skin samples without disturbing other input properties, (2) maps single-sample rare lesions onto novel skin-tones and locations non-parametrically, and (3) allows for efficient parametric generation with as few as 10 training samples. The framework supports both human and automated segmentation masking, enabling scalability to datasets without pre-made lesion masks. We grow a 656-image dataset by more than 400x and validate across two datasets: biopsy-confirmed Diverse Dermatology Images (DDI) and expert-verified Fitzpatrick17k (F17k). On the DDI benchmark, we achieve malignancy classification accuracy of 86.4% under synthetic-only training and 90.9% state-of-the-art performance with real data fine-tuning, alongside leading fairness metrics. Cross-dataset experiments show +13.9% accuracy improvements on unseen F17k data despite minimal disease overlap. We openly release 266k+ synthetic images, code, and generative models to further support fairness research at https://github.com/hectorcarrion/ControllableGenDDI.

This study presents a methodology for constructing a clinically verified dataset of dermatoscopic images for medical informatics research. The relevance of the work is driven by the fact that the performance of automated diagnostic support systems depends not only on the volume of images, but also on the reproducibility of the image acquisition procedure, the completeness of structured metadata, and the reliability of diagnostic labels. International collections were primarily created under conditions that differ substantially from routine Russian outpatient practice and mobile dermatoscopy. The proposed methodology integrates three interconnected components: (1) a standard operating procedure (SOP) for acquiring images via mobile dermatoscopy, (2) an information model comprising 16 structured metadata fields organized into six clinically oriented blocks in ISIC-compatible notation, and (3) a multi-stage expert verification of diagnostic labels (initial clinical annotation, consensus review by three specialists, and histological confirmation of all malignant neoplasms). Using this methodology, a dataset of 1,026 unique dermatoscopic images from 443 patients was collected between June 2025 and May 2026. From 1,044 initial records, 18 duplicates were excluded. The dataset includes nine nosological categories; all 39 malignant lesions (18 melanomas, 15 basal cell carcinomas, and 6 squamous cell carcinomas) were histologically verified. Patient age ranged from 2 to 90 years (median 38), with 279 females (63%) and 164 males (37%). Each image is accompanied by expert-annotated dermatoscopic structures and an explicit verification_stage field indicating the level of diagnostic confirmation. The resulting dataset serves as a pilot clinically verified resource suitable for independent model evaluation, domain shift analysis, interpretability studies, and further expansion.